Invitae Familial Hemiplegic Migraine Panel
Use
The Invitae Familial Hemiplegic Migraine Panel analyzes genes associated with familial hemiplegic migraine, alternating hemiplegia of childhood, and related conditions. Broad panel testing allows for efficient evaluation of several potential genes based on a single clinical indication. Genetic testing can help confirm a clinical diagnosis, predict disease prognosis and progression, and inform family planning and genetic counseling.
Special Instructions
This panel can be customized by clicking genes to remove them, allowing for a tailored approach based on clinical judgment. The test includes full-gene sequencing and deletion/duplication analysis using next-generation sequencing technology (NGS).
Limitations
The assay covers coding exons and select non-coding variants but does not cover certain types of variants like structural rearrangements or regions with complex architecture. Variants outside detailed regions are not analyzed. Single-exon copy number events may occasionally be unassessable due to sequence properties.
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
10-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
3mL
Minimum Volume
Not provided
Container
purple-top EDTA tube (K2EDTA or K3EDTA)